Multitrial evaluation of progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in previously untreated extensive-stage small cell lung cancer (ES-SCLC): An Alliance-led analysis.
Nathan R. Foster
No relevant relationships to disclose
Lindsay A. Renfro
No relevant relationships to disclose
Steven E. Schild
No relevant relationships to disclose
Mary Weber Redman
No relevant relationships to disclose
Xiaofei F. Wang
No relevant relationships to disclose
Suzanne Eleanor Dahlberg
No relevant relationships to disclose
Keyue Ding
No relevant relationships to disclose
Penelope Ann Bradbury
No relevant relationships to disclose
Suresh S. Ramalingam
No relevant relationships to disclose
David R. Gandara
No relevant relationships to disclose
Everett E. Vokes
No relevant relationships to disclose
Alex A. Adjei
No relevant relationships to disclose
Sumithra J. Mandrekar
No relevant relationships to disclose